Alpine Associates Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,349,966
Closed -$7.14M 58
2024
Q4
$7.14M Sell
2,349,966
-1,812,895
-44% -$5.51M 0.43% 38
2024
Q3
$21.6M Buy
+4,162,861
New +$21.6M 0.99% 32